Arrowhead Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ARWR and other ETFs, options, and stocks.

About ARWR

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC.

CEO

Christopher Richard Anzalone

CEOChristopher Richard Anzalone

Employees

329

Employees329

Headquarters

Pasadena, California

HeadquartersPasadena, California

Founded

1989

Founded1989

Employees

329

Employees329

ARWR Key Statistics

Market cap

3.50B

Market cap3.50B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

853.29K

Average volume853.29K

High today

$35.12

High today$35.12

Low today

$33.00

Low today$33.00

Open price

$33.20

Open price$33.20

Volume

968.87K

Volume968.87K

52 Week high

$84.83

52 Week high$84.83

52 Week low

$26.81

52 Week low$26.81

ARWR News

Simply Wall St 4d

Swelling losses haven't held back gains for Arrowhead Pharmaceuticals shareholders since they're up 566% over 5 years - Simply Wall St

Arrowhead Pharmaceuticals, Inc. ( ) shareholders have seen the share price descend 26% over the month. But that does not change the realty that the stock's perf...

Analyst ratings

82%

of 11 ratings

Buy

81.8%

Hold

18.2%

Sell

ARWR Earnings

-$0.68

-$0.32

$0.05

$0.41

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 21, After Hours

ActualExpected Nov 21, After Hours